Archives

Development of CAR T Cell therapy in Korea

Companies in Korea takes a step closer in developing home grown CAR T-Cell therapy

May 3rd, 2023 Cancer treatment in South Korea, CAR T-Cell therapy

May 2023: Chimeric antigen receptor (CAR) T-cell therapy is an innovative development in the field of individualized cancer therapy. The patient's own T-cells are genetically modified during the manufacturing process to express a synthetic rece.... Read More

Polatuzumab

Polatuzumab vedotin-piiq is approved by USFDA for previously untreated diffuse large B-cell lymphoma, not otherwise specified, and high-grade B-cell lymphoma

May 2nd, 2023 Blood cancer, Cancer, Lymphoma

May 2023: For adult patients with high-grade B-cell lymphoma (HGBL), not otherwise specified (NOS), or diffuse large B-cell lymphoma (DLBCL) who have not previously received treatment and who have an International Prognostic Index (IPI) score o.... Read More

Omidubicel - 2 May (1)

Omidubicel is approved by USFDA to reduce time to neutrophil recovery and infection in patients with hematologic malignancies

May 2nd, 2023 Blood cancer, Cancer

May 2023: Omidubicel-onlv (Omisirge, Gamida Cell Ltd.) was approved by the Food and Drug Administration for use in adult and paediatric patients (12 years of age and older) with hematologic malignancies who are scheduled to receive an umbilical.... Read More

Padcev for urothelial cancer treatment

Enfortumab vedotin-ejfv with pembrolizumab is approved by USFDA for locally advanced or metastatic urothelial carcinoma

May 2nd, 2023 Cancer, Urethral cancer

May 2023: Enfortumab vedotin-ejfv (Padcev, Astellas Pharma) and pembrolizumab (Keytruda, Merck) have been given accelerated approval by the Food and Drug Administration for the treatment of patients with locally advanced or metastatic urothelia.... Read More

Merkel cell carcinoma treatment

Retifanlimab-dlwr is approved by FDA for metastatic or recurrent locally advanced Merkel cell carcinoma

April 26th, 2023 Cancer, Cancer treatment in China, Cancer treatment in India, Cancer treatment in Israel, Cancer treatment in Japan, Cancer treatment in Malaysia, Cancer treatment in South Korea, cancer treatment in Thailand, Cancer treatment in Turkey, Merkel cell carcinoma

April 2023: Retifanlimab-dlwr (Zynyz, Incyte Corporation) received fast approval from the Food and Drug Administration to treat adult patients with metastatic or recurrent locally advanced Merkel cell cancer (MCC). In PODIUM-201 (NCT03599713.... Read More

Tumor Infiltrating Lymphocytes (TIL) Immunotherapy is a promising approach in the field of cancer treatment

Tumor Infiltrating lymphocytes (TIL) Immunotherapy in India

April 7th, 2023 Cancer, Cancer treatment in India, Immunotherapy

April 2023: Using the body's immune system to fight cancer cells is the goal of the promising cancer treatment method known as tumour infiltrating lymphocytes (TIL) immunotherapy. The process entails taking immune cells called TILs out of a pat.... Read More

Esophageal cancer awareness month

Lesser known facts about esophageal cancer

April 5th, 2023 Esophageal cancer

April 2023: April month is observed as esophageal cancer awareness month. Esophageal cancer is a type of cancer that affects the esophagus, the muscular tube that connects the throat to the stomach. Here are some lesser-known facts about esopha.... Read More

Jayprica Lilly

Abemaciclib with endocrine therapy is approved by FDA in HER 2 positive breast cancer

March 24th, 2023 Breast Cancer, Cancer, Cancer treatment in China, Cancer treatment in India, Cancer treatment in Israel, Drugs

March 2023: Abemaciclib (Verzenio, Eli Lilly and Company) and endocrine therapy (tamoxifen or an aromatase inhibitor) have been approved by the Food and Drug Administration (FDA) for the adjuvant treatment of adult patients with early-stage, no.... Read More

Sam Neill actor

Sam Neill, “Jurassic Park” actor, has been diagnosed with blood cancer

March 19th, 2023 Blood cancer, Cancer, CAR T-Cell therapy

March 2023: The first chapter of Sam Neill's memoir would be a tremendous shock to someone who had no prior knowledge of it. It starts out funny enough: a great yarn about his daughter Elena being questioned about her father's job at school whe.... Read More

CAR T Cell therapy in ovarian cancer treatment

MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer

March 17th, 2023 Cancer, Cancer treatment in China, CAR T-Cell therapy, Ovarian Cancer

March 2023: Brief Summary: The goal of this clinical trial is to study the feasibility and efficacy of anti-MESO antigen receptors CAR T-cell therapy for relapsed and refractory epithelial ovarian cancer. Detailed Description: Pri.... Read More